Posted On: 11/03/2014 11:44:26 AM
Post# of 72750
$ARNA News
S&P 500 back for another crack at major support 11:21 a.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Arena Pharmaceuticals (ARNA) Q3 2014 Results - Earnings Call Webcast 8:25 a.m. Today - Seeking Alpha
Super Important Biotech and Drug Stock Events for November 8:24 a.m. Today - TheStreet.com
Arena Pharmaceuticals Reports Q3 Loss, Shares Surge 6% 7:37 a.m. Today - benzinga.com
Arena Pharma Reports Q3 EPS Loss $0.05, Revenues Of $8.16M Vs. Est. Of $11.0M 5:48 a.m. Today - benzinga.com
Arena Pharmaceuticals, Inc., Loews Corporation, and Sysco Corporation: Today’s Earnings Movers 4:57 a.m. Today - InvestorPlace.com
Earnings Scheduled For November 3, 2014 4:18 a.m. Today - benzinga.com
Belviq Sales Recover From Holiday - Sales Flat In Q4 Thus Far 4:51 p.m. Oct. 31, 2014 - Seeking Alpha
Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected? - Analyst Blog 3:34 p.m. Oct. 31, 2014 - Zacks.com
Eisai Earnings Give Arena Investors Insights 10:33 a.m. Oct. 31, 2014 - Seeking Alpha
Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx 6:40 a.m. Oct. 31, 2014 - TheStreet.com
3 Pharma Companies Fighting Obesity 1:00 p.m. Oct. 30, 2014 - benzinga.com
Arena Offers Tease On Belviq And Phentermine 11:02 a.m. Oct. 29, 2014 - Seeking Alpha
Arena Skimps on Data Disclosure from Weight-Loss Combo Study 7:30 a.m. Oct. 29, 2014 - TheStreet.com
Belviq Sales Dip During Holiday Week, Should Show Steady Progress From Here 7:38 a.m. Oct. 27, 2014 - Seeking Alpha
Assessing Arena Pharmaceutical Belviq Sales And The Impact Of TV Ads 9:16 a.m. Oct. 22, 2014 - Seeking Alpha
Arena Investors Need To Watch Contrave Launch Closely 9:08 a.m. Oct. 22, 2014 - Seeking Alpha
Orexigen (OREX) Stock Shoots Higher as Contrave Goes on Sale 11:08 a.m. Oct. 21, 2014 - InvestorPlace.com
Orexigen Launches Contrave - Watch For Traction 2:01 p.m. Oct. 20, 2014 - Seeking Alpha
Belviq Sales Dip: What To Watch For Ahead 1:13 p.m. Oct. 17, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results 6:45 a.m. Today - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation 6:30 a.m. Today - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:37 a.m. Oct. 31, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl 5:20 p.m. Oct. 28, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3 7:00 a.m. Oct. 27, 2014 - PR Newswire - PRF
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 8:30 a.m. Oct. 17, 2014 - PR Newswire - PRF
Global Anti-Obesity Drugs Market 4:07 p.m. Oct. 16, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) CIV in Postgraduate Medicine 10:36 a.m. Oct. 10, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 7:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7:15 a.m. Sept. 19, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 7:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Post-Earnings Review and Highlights - Arena Pharma 8:30 a.m. Aug. 11, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3:30 a.m. Aug. 1, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7:00 a.m. July 30, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in the Best Pharmaceutical Agent Category 7:00 a.m. July 29, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 7:00 a.m. July 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Israel 7:00 a.m. July 21, 2014 - PR Newswire - PRF
Cannabis Based Healing Products Lead Commercialization For Medical Marijuana Patients - Company Introduces New Edible CBD-Rich Product Line 7:30 a.m. July 16, 2014 - PR Newswire - PRF
S&P 500 back for another crack at major support 11:21 a.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Arena Pharmaceuticals (ARNA) Q3 2014 Results - Earnings Call Webcast 8:25 a.m. Today - Seeking Alpha
Super Important Biotech and Drug Stock Events for November 8:24 a.m. Today - TheStreet.com
Arena Pharmaceuticals Reports Q3 Loss, Shares Surge 6% 7:37 a.m. Today - benzinga.com
Arena Pharma Reports Q3 EPS Loss $0.05, Revenues Of $8.16M Vs. Est. Of $11.0M 5:48 a.m. Today - benzinga.com
Arena Pharmaceuticals, Inc., Loews Corporation, and Sysco Corporation: Today’s Earnings Movers 4:57 a.m. Today - InvestorPlace.com
Earnings Scheduled For November 3, 2014 4:18 a.m. Today - benzinga.com
Belviq Sales Recover From Holiday - Sales Flat In Q4 Thus Far 4:51 p.m. Oct. 31, 2014 - Seeking Alpha
Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected? - Analyst Blog 3:34 p.m. Oct. 31, 2014 - Zacks.com
Eisai Earnings Give Arena Investors Insights 10:33 a.m. Oct. 31, 2014 - Seeking Alpha
Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx 6:40 a.m. Oct. 31, 2014 - TheStreet.com
3 Pharma Companies Fighting Obesity 1:00 p.m. Oct. 30, 2014 - benzinga.com
Arena Offers Tease On Belviq And Phentermine 11:02 a.m. Oct. 29, 2014 - Seeking Alpha
Arena Skimps on Data Disclosure from Weight-Loss Combo Study 7:30 a.m. Oct. 29, 2014 - TheStreet.com
Belviq Sales Dip During Holiday Week, Should Show Steady Progress From Here 7:38 a.m. Oct. 27, 2014 - Seeking Alpha
Assessing Arena Pharmaceutical Belviq Sales And The Impact Of TV Ads 9:16 a.m. Oct. 22, 2014 - Seeking Alpha
Arena Investors Need To Watch Contrave Launch Closely 9:08 a.m. Oct. 22, 2014 - Seeking Alpha
Orexigen (OREX) Stock Shoots Higher as Contrave Goes on Sale 11:08 a.m. Oct. 21, 2014 - InvestorPlace.com
Orexigen Launches Contrave - Watch For Traction 2:01 p.m. Oct. 20, 2014 - Seeking Alpha
Belviq Sales Dip: What To Watch For Ahead 1:13 p.m. Oct. 17, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results 6:45 a.m. Today - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation 6:30 a.m. Today - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:37 a.m. Oct. 31, 2014 - PR Newswire - PRF
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl 5:20 p.m. Oct. 28, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3 7:00 a.m. Oct. 27, 2014 - PR Newswire - PRF
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 8:30 a.m. Oct. 17, 2014 - PR Newswire - PRF
Global Anti-Obesity Drugs Market 4:07 p.m. Oct. 16, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) CIV in Postgraduate Medicine 10:36 a.m. Oct. 10, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 7:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7:15 a.m. Sept. 19, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 7:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Post-Earnings Review and Highlights - Arena Pharma 8:30 a.m. Aug. 11, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3:30 a.m. Aug. 1, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7:00 a.m. July 30, 2014 - PR Newswire - PRF
Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in the Best Pharmaceutical Agent Category 7:00 a.m. July 29, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 7:00 a.m. July 25, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Israel 7:00 a.m. July 21, 2014 - PR Newswire - PRF
Cannabis Based Healing Products Lead Commercialization For Medical Marijuana Patients - Company Introduces New Edible CBD-Rich Product Line 7:30 a.m. July 16, 2014 - PR Newswire - PRF
(0)
(0)
